Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Erythrocyte blood group antigens and alterations of the hormonal status among the reproductive age women with breast tumors

Irina Nakashidze, Nanuli Kotrikadze, Anzor Diasamidze, Marina Nagervadze, Manana Alibegashvili, Liana Ramishvili, Manana Gordeziani

. 2014 ; 7 (1) : 14-18.

Jazyk angličtina Země Česko Médium elektronický zdroj

Perzistentní odkaz   https://www.medvik.cz/link/bmc15010744

The significance of ABO blood system groups antigens in development of some malignant tumors is already established. The alteration of hormonal homeostasis must also be taken into account. Hence the aim of the investigation was to study ABO and Rh blood system antigens and hormonal status among reproductive age women with benign and malignant breast tumors. Methods: The determination of hormones was made by the enzymatic analysis method (ELAIZA), provided by proper ELAIZA kits. For the study of ABO and Rh­Hr system antigens, internationally recognized immunoserology methods were used. Results: High index of the breast gland tumors were revealed in patients with A(II) phenotypic group, according to the ABO system. The frequency distribution of O(I) phenotypic group was low among women with breast tumors. Among D, C, E, c and e antigens of the Rh system, the frequency of D and E antigens were increased in benign and malignant breast tumors patients. The study of hormonal balance revealed thyroid gland hypofunction and increased level of estradiol on the background of increased testosterone and decreased progesterone levels. Such hormonal imbalance and excess production of estradiol creates conditions for malignant tumor formation in reproductive age women. Conclusion: The highest frequency of breast cancer in reproductive age was revealed in A(II) group patients. The wide spectrum of hormonal disorders were revealed in breast tumor patients of the reproductive age, which was especially clear in cases of malignant tumor.

Erythrocyte blood group antigens and alterations of the hormonal status among the reproductive age women with breast tumors [elektronický zdroj] /

Citace poskytuje Crossref.org

Bibliografie atd.

Literatura

000      
00000naa a2200000 a 4500
001      
bmc15010744
003      
CZ-PrNML
005      
20190528124537.0
007      
cr|cn|
008      
150322s2014 xr fs 000 0|eng||
009      
eAR
024    7_
$a 10.12955/emhpj.v7i1.429 $2 doi
040    __
$a ABA008 $d ABA008 $e AACR2 $b cze
041    0_
$a eng
044    __
$a xr
100    1_
$a Nakashidze, Irina $u Department of Biology, Faculty of Education and Sciences, Batumi Shota Rustaveli State University, Batumi, Georgia
245    10
$a Erythrocyte blood group antigens and alterations of the hormonal status among the reproductive age women with breast tumors $h [elektronický zdroj] / $c Irina Nakashidze, Nanuli Kotrikadze, Anzor Diasamidze, Marina Nagervadze, Manana Alibegashvili, Liana Ramishvili, Manana Gordeziani
504    __
$a Literatura
520    9_
$a The significance of ABO blood system groups antigens in development of some malignant tumors is already established. The alteration of hormonal homeostasis must also be taken into account. Hence the aim of the investigation was to study ABO and Rh blood system antigens and hormonal status among reproductive age women with benign and malignant breast tumors. Methods: The determination of hormones was made by the enzymatic analysis method (ELAIZA), provided by proper ELAIZA kits. For the study of ABO and Rh­Hr system antigens, internationally recognized immunoserology methods were used. Results: High index of the breast gland tumors were revealed in patients with A(II) phenotypic group, according to the ABO system. The frequency distribution of O(I) phenotypic group was low among women with breast tumors. Among D, C, E, c and e antigens of the Rh system, the frequency of D and E antigens were increased in benign and malignant breast tumors patients. The study of hormonal balance revealed thyroid gland hypofunction and increased level of estradiol on the background of increased testosterone and decreased progesterone levels. Such hormonal imbalance and excess production of estradiol creates conditions for malignant tumor formation in reproductive age women. Conclusion: The highest frequency of breast cancer in reproductive age was revealed in A(II) group patients. The wide spectrum of hormonal disorders were revealed in breast tumor patients of the reproductive age, which was especially clear in cases of malignant tumor.
650    _2
$a ABO systém krevních skupin $x imunologie $x krev $7 D000017
650    _2
$a krevní skupiny - systém Rh-Hr $x imunologie $x krev $7 D012204
650    12
$a nádory prsu $x imunologie $x krev $x patofyziologie $7 D001943
650    _2
$a pohlavní steroidní hormony $x krev $7 D012739
650    _2
$a hormony štítné žlázy $x krev $7 D013963
650    _2
$a prolaktin $x krev $7 D011388
650    _2
$a nádorové procesy $7 D009385
650    _2
$a dospělí $7 D000328
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a lidé středního věku $7 D008875
650    _2
$a kohortové studie $7 D015331
700    1_
$a Kotrikadze, Nanuli $u Department of Biology, Faculty of Exact and Natural Sciences, Ivane Javakhishvili Tbilisi State University, Tbilisi, Georgia
700    1_
$a Diasamidze, Anzor $u Department of Biology, Faculty of Education and Sciences, Batumi Shota Rustaveli State University, Batumi, Georgia
700    1_
$a Nagervadze, Marina $u Department of Biology, Faculty of Education and Sciences, Batumi Shota Rustaveli State University, Batumi, Georgia
700    1_
$a Alibegashvili, Manana $u Department of Biology, Faculty of Exact and Natural Sciences, Ivane Javakhishvili Tbilisi State University, Tbilisi, Georgia $7 gn_A_00004209
700    1_
$a Ramishvili, Liana $u Department of Biology, Faculty of Exact and Natural Sciences, Ivane Javakhishvili Tbilisi State University, Tbilisi, Georgia
700    1_
$a Gordeziani, Manana $u Department of Biology, Faculty of Exact and Natural Sciences, Ivane Javakhishvili Tbilisi State University, Tbilisi, Georgia
773    0_
$t European medical, health and pharmaceutical journal $x 1804-5804 $g Roč. 7, č. 1 (2014), s. 14-18 $w MED00177703
856    41
$u https://ojs.journals.cz/index.php/EMHPJ/issue/view/49 $y plný text volně přístupný
910    __
$a ABA008 $y 4 $z 0
990    __
$a 20150321103405 $b ABA008
991    __
$a 20190528124701 $b ABA008
999    __
$a ok $b bmc $g 1068195 $s 893582
BAS    __
$a 3 $a 4
BMC    __
$a 2014 $b 7 $c 1 $d 14-18 $i 1804-5804 $m European Medical, Health and Pharmaceutical Journal $n Eur. Med. Health Pharm. J. $x MED00177703
LZP    __
$c NLK121 $d 20151113 $a NLK 2015-16/vt

Najít záznam

Citační ukazatele

Možnosti archivace